AB0315 High Disease Activity at Baseline, Not Rf Nor Acpa Status, Predicts Inadequate Response to Methotrexate (MTX) in Patients With Early Rheumatoid Arthritis in Real World: A Single Centrecohort in Japan

doi 10.1136/annrheumdis-2018-eular.2666
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

IgG Fc Galactosylation Predicts Response to Methotrexate in Early Rheumatoid Arthritis

Arthritis Research & Therapy
2017English

Increase in Methotrexate Dose in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Infliximab

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2005English

Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2017English

MTX Use in Japanese Patients With Rheumatoid Arthritis

Arthritis Care and Research
Rheumatology
2018English

AB0344 Subclinical Vascular Damage and Its Association With Acpa and Rf in Patients With Rheumatoid Arthritis

2017English

The P. Gingivalis Autocitrullinome Is Not a Target for ACPA in Early Rheumatoid Arthritis

Journal of Dental Research
Dentistry
2020English

Influence of Therapy With Methotrexate, Sulfasalazine and Glucocorticoids on Disease Activity and Erosions Progression in Patients With Early Rheumatoid Arthritis

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2007English

Achieving Comprehensive Disease Control in Patients With Early and Established Rheumatoid Arthritis Treated With Adalimumab Plus Methotrexate Versus Methotrexate Alone

RMD Open
RheumatologyAllergyImmunology
2017English

A Population Model of Early Rheumatoid Arthritis Disease Activity During Treatment With Methotrexate, Sulfasalazine and Hydroxychloroquine

British Journal of Clinical Pharmacology
Pharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy